Standing Committee for Clinical Affairs
Clinical trials supported by EULAR
Ongoing initiatives
|
ASTIS (Autologous Stem Cell Transplantation International Scleroderma) trial
Convenor: Jacob van Laar, Dominique Farge, Alan Tyndall
|
|
SAVE: evaluation of the efficacy of a single injection of steroids in early arthritis
Convenor: Klaus Machold
|
|
PROMETHEUS: to test the role of methotrexate added to corticisetroid in the treatment of polymyositis and dermatomyositis
Convenor: Jiri Vencovsky
|
|
Study protocol for the European Team Initiative for Care Research (ETIC), incl. the STAR project
Convenor: Ingemar Petersson
|
RELATED INFORMATION
How to apply
An application (synopsis of the protocol including the evaluated treatments, the characteristics of the disease to be treated, the primary outcome variable and the potential participating centers) should be sent to the chairman of ESCCA at least 6 weeks prior to the upcoming Executive Committee meeting (in general mid-March, June at the congress and second-half of September).
Such applications will be reviewed by two external reviewers, and the decision to support this trial will be with the EULAR Executive Committee. Support can be at two levels: scientific support and potential financial support from EULAR.
In all cases, any financial support obtained and/or expected by bodies different than EULAR has to be clearly mentioned in the application.